1. Yurgelun, Matthew B, Kulke, Matthew H, Fuchs, Charles S, Wenstrup, Richard J, Syngal, Sapna. 2017. Cancer Susceptibility Gene Mutations in Individuals With Colorectal Cancer. In Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 35, 1086-1095. doi:10.1200/JCO.2016.71.0012. https://pubmed.ncbi.nlm.nih.gov/28135145/
2. Delimitsou, Angeliki, Fostira, Florentia, Kalfakakou, Despoina, Voutsinas, Gerassimos E, Yannoukakos, Drakoulis. 2019. Functional characterization of CHEK2 variants in a Saccharomyces cerevisiae system. In Human mutation, 40, 631-648. doi:10.1002/humu.23728. https://pubmed.ncbi.nlm.nih.gov/30851065/
3. Yadav, Siddhartha, Boddicker, Nicholas J, Na, Jie, Kraft, Peter, Couch, Fergus J. 2023. Contralateral Breast Cancer Risk Among Carriers of Germline Pathogenic Variants in ATM, BRCA1, BRCA2, CHEK2, and PALB2. In Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 41, 1703-1713. doi:10.1200/JCO.22.01239. https://pubmed.ncbi.nlm.nih.gov/36623243/
4. Graffeo, R, Rana, H Q, Conforti, F, Lambertini, M, Garber, J E. 2022. Moderate penetrance genes complicate genetic testing for breast cancer diagnosis: ATM, CHEK2, BARD1 and RAD51D. In Breast (Edinburgh, Scotland), 65, 32-40. doi:10.1016/j.breast.2022.06.003. https://pubmed.ncbi.nlm.nih.gov/35772246/
5. Hauke, Jan, Horvath, Judit, Groß, Eva, Schmutzler, Rita K, Hahnen, Eric. 2018. Gene panel testing of 5589 BRCA1/2-negative index patients with breast cancer in a routine diagnostic setting: results of the German Consortium for Hereditary Breast and Ovarian Cancer. In Cancer medicine, 7, 1349-1358. doi:10.1002/cam4.1376. https://pubmed.ncbi.nlm.nih.gov/29522266/
6. Bychkovsky, Brittany L, Agaoglu, Nihat B, Horton, Carolyn, Garber, Judy E, Rana, Huma Q. . Differences in Cancer Phenotypes Among Frequent CHEK2 Variants and Implications for Clinical Care-Checking CHEK2. In JAMA oncology, 8, 1598-1606. doi:10.1001/jamaoncol.2022.4071. https://pubmed.ncbi.nlm.nih.gov/36136322/
智鼠故事 
